Innovent Biologics Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
06:40
Apr 27
Apr 27
Long Innovent Biologics and Hengrui Medicine.
She recommends Innovent Biologics and Hengrui Medicine as top picks in the Chinese pharmaceutical sector. Innovent is a maturing biopharma transitioning to global level with a strong pipeline and deal-making capability. Hengrui is a traditional company successfully phasing out legacy products and replenishing with innovative drugs. Both have clinical catalysts and are positioned to benefit from China's growing dominance in global drug R&D.
HIGH
About Innovent Biologics Analyst Coverage
Buzzberg tracks Innovent Biologics across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.